When should insulin be initiated and what is the recommended initial dosing regimen for an adult with diabetes?

Insulin Initiation and Dosing in Adults with Diabetes

When to Start Insulin

Insulin should be initiated immediately in adults with type 2 diabetes when HbA1c ≥10% (86 mmol/mol) with symptomatic hyperglycemia, or when blood glucose ≥300-350 mg/dL with catabolic features, as these patients require urgent glycemic control to prevent metabolic decompensation. 1

For less severe presentations:

• Start insulin when HbA1c ≥7.5% (58 mmol/mol) despite optimal oral medications (metformin plus additional agents), as alternative therapies become insufficient at this threshold 2
• Consider earlier initiation when HbA1c ≥9%, as most oral agents reduce HbA1c by <1% and cannot achieve target glycemic control at this severity 1
• Insulin is mandatory for all patients with type 1 diabetes at diagnosis, requiring immediate multiple daily injections 2

---

Initial Dosing Regimens

Type 2 Diabetes: Basal Insulin Approach

For insulin-naive adults with type 2 diabetes and HbA1c 7.5-9%, start with 10 units of long-acting basal insulin (glargine, detemir, or degludec) once daily at bedtime, OR use weight-based dosing of 0.1-0.2 units/kg/day. 1, 3

• Continue metformin at maximum tolerated dose (up to 2000-2550 mg daily) when adding insulin, as this combination reduces total insulin requirements by 20-30% and limits weight gain 1, 2
• Administer basal insulin at the same time each day, preferably at 20:00h (8 PM) to maintain stable 24-hour coverage 1

Type 2 Diabetes: Severe Hyperglycemia (HbA1c ≥10%)

For patients with HbA1c ≥10% or blood glucose ≥300-350 mg/dL with symptoms, initiate basal-bolus therapy immediately with 0.3-0.5 units/kg/day total daily dose, split 50% basal and 50% prandial insulin. 1

• Give 50% as basal insulin once daily (e.g., 21-35 units for a 70 kg patient) 1
• Divide remaining 50% as rapid-acting insulin before three main meals (e.g., 7-12 units per meal) 1
• This aggressive approach is essential because sliding-scale insulin alone achieves target glucose in only 38% of patients versus 68% with basal-bolus therapy 1

Type 1 Diabetes: Multiple Daily Injections

For adults with type 1 diabetes, start with 0.5 units/kg/day total daily dose (range 0.4-1.0 units/kg/day), divided as 40-50% basal insulin and 50-60% prandial insulin. 1, 2

• Basal component: 11-14 units once daily of long-acting analog (glargine or detemir) at bedtime 1
• Prandial component: 14-16 units total of rapid-acting insulin (lispro, aspart, or glulisine) divided across three meals (4-5 units per meal), given 0-15 minutes before eating 1, 2
• Higher doses (0.6-1.0 units/kg/day) are required when presenting with diabetic ketoacidosis 1

---

Titration Protocols

Basal Insulin Adjustment

Increase basal insulin by 2 units every 3 days when fasting glucose is 140-179 mg/dL, or by 4 units every 3 days when fasting glucose ≥180 mg/dL, until reaching target fasting glucose of 80-130 mg/dL. 1

• If hypoglycemia occurs without clear cause, reduce the dose by 10-20% immediately 1
• Daily fasting glucose monitoring is essential during titration to guide dose adjustments 1

Critical Threshold: When to Stop Escalating Basal Insulin

When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day without achieving glycemic targets, add prandial insulin rather than continuing to escalate basal insulin alone. 1

This threshold prevents "overbasalization"—a dangerous pattern where excessive basal insulin masks the need for mealtime coverage, causing:

• Bedtime-to-morning glucose differential ≥50 mg/dL 1
• Increased hypoglycemia risk 1
• High glucose variability throughout the day 1

Prandial Insulin Initiation and Titration

Start with 4 units of rapid-acting insulin before the largest meal, OR use 10% of the current basal dose, then increase by 1-2 units (or 10-15%) every 3 days based on 2-hour postprandial glucose readings. 1

• Target postprandial glucose <180 mg/dL 1
• Administer rapid-acting insulin 0-15 minutes before meals for optimal postprandial control 1, 2

---

Special Populations and Situations

Hospitalized Patients

For non-critically ill hospitalized patients requiring insulin, start with 0.3-0.5 units/kg/day total dose (50% basal, 50% prandial) for standard-risk patients, or 0.1-0.25 units/kg/day for high-risk patients (age >65 years, renal impairment, poor oral intake). 1

• If home insulin dose was ≥0.6 units/kg/day, reduce total daily dose by 20% on admission to prevent hypoglycemia 1
• Check point-of-care glucose before each meal and at bedtime for patients eating regular meals 1
• Target glucose 140-180 mg/dL for most non-critically ill hospitalized patients 1

NPO/Poor Oral Intake

For patients who are NPO or have limited intake, provide basal insulin at approximately 75-80% of usual dose plus correction doses only; check glucose every 4-6 hours. 1

• Never completely withhold basal insulin in NPO patients, as it suppresses hepatic glucose production independent of food intake and prevents ketoacidosis 1
• Reduce perioperative basal insulin by 25% the evening before surgery to achieve target glucose with decreased hypoglycemia risk 1

Renal Impairment

For patients with CKD Stage 5, reduce total daily insulin dose by 50% for type 2 diabetes and by 35-40% for type 1 diabetes. 1

• Titrate conservatively when eGFR <45 mL/min/1.73 m² to avoid hypoglycemia 1
• Monitor more frequently for hypoglycemia as insulin clearance decreases with declining kidney function 1

---

Common Pitfalls to Avoid

Never Use Sliding-Scale Insulin as Monotherapy

Sliding-scale insulin as the sole regimen is condemned by all major diabetes guidelines because it treats hyperglycemia reactively after it occurs, resulting in dangerous glucose fluctuations. 1

• Only 38% of patients on sliding-scale alone achieve mean glucose <140 mg/dL versus 68% with scheduled basal-bolus therapy 1
• Correction doses should only supplement scheduled basal and prandial insulin, never replace them 1

Do Not Delay Insulin Initiation

Delaying insulin in patients not achieving glycemic goals with oral medications prolongs hyperglycemia exposure and increases complication risk. 1

• Therapeutic inertia should be prevented—intensify therapy within 3 months if HbA1c remains above target 4

Do Not Discontinue Metformin When Starting Insulin

Metformin must be continued when adding or intensifying insulin therapy unless contraindicated (eGFR <30 mL/min/1.73 m²), as it reduces insulin requirements and limits weight gain. 1, 2

Do Not Give Rapid-Acting Insulin at Bedtime

Never administer rapid-acting insulin solely at bedtime as a correction dose, as this markedly increases nocturnal hypoglycemia risk. 1

Avoid Overbasalization

Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as this leads to suboptimal control and increased hypoglycemia risk. 1

---

Monitoring and Safety

Hypoglycemia Management

Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate, recheck in 15 minutes, and repeat if needed. 1

• If hypoglycemia occurs without obvious cause, reduce the implicated insulin dose by 10-20% promptly 1

Follow-up Schedule

• Reassess HbA1c every 3 months during intensive titration until target is achieved, then every 6 months once stable 1, 4
• If HbA1c remains >7% after 3-6 months despite optimized basal insulin, add prandial insulin or a GLP-1 receptor agonist 1

Patient Education Essentials

All patients starting insulin require education on:

• Proper injection technique and site rotation to prevent lipohypertrophy 1, 2
• Hypoglycemia recognition and treatment (symptoms, <70 mg/dL threshold, 15-gram carbohydrate rule) 1
• Self-monitoring of blood glucose—at least 4 daily measurements during titration 1
• "Sick day" management: continue insulin even if not eating, check glucose every 4 hours, maintain hydration 1
• Ketone testing when glucose >300 mg/dL with nausea/vomiting 1